STOCK TITAN

C3is Inc. (CISS) Financials

CISS
FY2025 annual
Revenue $34.8M -17.8% YoY
Net Income $10.5M +481.1% YoY
EPS (Diluted) $3.98 YoY not available
Free Cash Flow $3.8M -83.6% YoY
Market Cap $2.7M as of Oct 10, 2026
Price / Sales 0.1x on $34.8M revenue, FY2025
Price / Earnings 0.3x on $10.5M net income, FY2025
Price / Book 0.0x on $95.1M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 22, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CISS SEC filings page.

C3is Inc. (CISS) reported $34.8M in revenue for fiscal year 2025, down 17.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CISS FY2025

Positive reported profit came with weaker core operations, while balance-sheet leverage fell and cash conversion remained uneven.

In FY2025, net income of $10.5M far exceeded operating income of $1.4M. That gap, following FY2024's operating profit of $10.1M alongside a net loss of $2.7M, indicates that below-operating-line items materially shaped reported earnings in both years.

FY2025 operating cash flow was $4.0M against net income of $10.5M, so reported earnings did not translate fully into cash. The prior year's $23.4M free cash flow despite a $2.7M net loss reinforces that cash generation and accounting profit can move in opposite directions.

Liabilities fell from $29.1M in FY2024 to $3.4M in FY2025, materially reducing balance-sheet leverage. Capital expenditures were only $162K against $4.0M of operating cash flow, indicating that FY2025 cash generation required little reinvestment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 77 / 100
Financial Health Score 77/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of C3is Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
71

C3is Inc. has an operating margin of 3.9%, meaning the company retains $4 of operating profit per $100 of revenue. This strong profitability earns a score of 71/100, reflecting efficient cost management and pricing power. This is down from 23.8% the prior year.

Growth
65

C3is Inc.'s revenue declined 17.8% year-over-year, from $42.3M to $34.8M. This contraction results in a growth score of 65/100.

Leverage
85

C3is Inc. carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
94

With a current ratio of 6.21, C3is Inc. holds $6.21 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 94/100.

Cash Flow
89

C3is Inc. converts 11.1% of revenue into free cash flow ($3.8M). This strong cash generation earns a score of 89/100.

Returns
56

C3is Inc.'s ROE of 11.0% shows moderate profitability relative to equity, earning a score of 56/100. This is up from -3.9% the prior year.

Altman Z-Score Distress
1.15

C3is Inc. scores 1.15, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

C3is Inc. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
0.38x

For every $1 of reported earnings, C3is Inc. generates $0.38 in operating cash flow ($4.0M OCF vs $10.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Safe
162.49x

C3is Inc. earns $162.49 in operating income for every $1 of interest expense ($1.4M vs $8K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$617K
YoY-86.7%
QoQ-8.8%

C3is Inc. held $617K in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
659,668
QoQ-28.6%

C3is Inc. had 659,668 shares outstanding in Q4 2025. Against the prior quarter it is down 28.6%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

CISS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CISS quarterly income statement
MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CISS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CISS quarterly balance sheet
MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-K
Total Assets$98.5M-2.0%$90.1M-34.4%$100.5M+5.3%$137.4M$95.5M+139.5%$39.9M
Current Assets$20.8M+27.5%$9.2M-81.6%$16.3M-19.6%$50.0M$20.3M+1884.4%$1.0M
Cash & Equivalents$617K-86.7%$676K-97.9%$4.6M+567.4%$32.3M$695K$0
Short-Term Investments$0$0$0$0$0$0
Inventory$1.3M+48.4%$1.1M+3.0%$884K+28.3%$1.1M$689K+316.1%$166K
Long-Term Investments$0$0$0$0$0$0
Total Liabilities$3.4M-88.4%$15.5M-78.2%$29.1M-27.0%$71.1M$39.9M+4035.6%$965K
Current Liabilities$3.4M-82.0%$5.7M-89.9%$18.7M-53.2%$56.6M$39.9M+4035.6%$965K
Non-Current Liabilities$29K-99.7%$9.8M-32.4%$10.4M$14.5M$0$0
Total Equity$95.1M+33.3%$74.6M+12.5%$71.4M+28.5%$66.3M$55.5M+42.8%$38.9M
Retained Earnings$4.5M+1645.1%$650K+122.7%$257K-96.9%-$2.9M$8.3MN/A

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.

CISS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CISS quarterly cash flow statement
MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

CISS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CISS quarterly financial ratios
MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-K
Current Ratio6.21+5.3x1.61+0.7x0.87+0.4x0.880.51-0.6x1.06
Debt-to-Equity0.04-0.4x0.21-0.9x0.41-0.3x1.070.72+0.7x0.02

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
C3is Inc. CISS FY2025 $34.8M $10.5M 30.1% $2.7M 77/100
Icon Energy Corp. ICON FY2025 $1.7M -$4.2M N/A $3.2M 46/100
Castor Maritime Inc. CTRM FY2025 $81.8M $19.3M 23.5% $16.4M 42/100
United Maritime Corporation USEA FY2025 $37.8M -$6.2M -16.4% $24.2M 26/100
Globus Maritime Limited GLBS FY2025 $44.2M -$1.7M -4.0% $72.3M 42/100

Frequently Asked Questions

What is C3is Inc.'s annual revenue?

C3is Inc. (CISS) reported $34.8M in total revenue for fiscal year 2025. This represents a -17.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is C3is Inc.'s revenue growing?

C3is Inc. (CISS) revenue declined by 17.8% year-over-year, from $42.3M to $34.8M in fiscal year 2025.

Is C3is Inc. profitable?

Yes, C3is Inc. (CISS) reported a net income of $10.5M in fiscal year 2025, with a net profit margin of 30.1%.

C3is Inc. (CISS) reported diluted earnings per share of $3.98 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

C3is Inc. (CISS) had EBITDA of $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

C3is Inc. (CISS) had an operating margin of 3.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

C3is Inc. (CISS) had a net profit margin of 30.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

C3is Inc. (CISS) has a return on equity of 11.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

C3is Inc. (CISS) generated $3.8M in free cash flow during fiscal year 2025. This represents a -83.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

C3is Inc. (CISS) generated $4.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

C3is Inc. (CISS) had $98.5M in total assets as of fiscal year 2025, including both current and long-term assets.

C3is Inc. (CISS) invested $162K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

C3is Inc. (CISS) had 659,668 shares outstanding as of fiscal year 2025.

C3is Inc. (CISS) had a current ratio of 6.21 as of fiscal year 2025, which is generally considered healthy.

C3is Inc. (CISS) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

C3is Inc. (CISS) had a return on assets of 10.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

C3is Inc. (CISS) trades at 0.3x earnings, its market capitalization divided by net income of $10.5M net income, FY2025. The market capitalization is $2.7M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

C3is Inc. (CISS) trades at 0.1x sales, its market capitalization divided by revenue of $34.8M revenue, FY2025. The market capitalization is $2.7M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

C3is Inc. (CISS) has an Altman Z-Score of 1.15, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

C3is Inc. (CISS) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

C3is Inc. (CISS) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

C3is Inc. (CISS) has an interest coverage ratio of 162.49x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

C3is Inc. (CISS) scores 77 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top